ArticleJournal of conservative dentistry and endodontics2025
Outcomes of vital pulp therapy using various pulp capping agents.
Article in Journal of conservative dentistry and endodontics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Biocompatibility of carbazochrome sodium sulfonate on human dental pulp stem cells: AnJournal of conservative dentistry and endodontics · 2026Article
- Effect of the combination of Solanesol fromJournal of conservative dentistry and endodontics · 2026Article
- Dose-dependent effects of Metformin on proliferation and odontogenic differentiation of dental pulp stem cells.BMC oral health · 2026Article
- Novel acemannan-integrated bioceramic for enhancing human dental pulp stem cell viability and transforming growth factor beta-1 release in pulp regeneration.Journal of conservative dentistry and endodontics · 2026Article
- Histological evaluation of keratin and keratin with tricalcium phosphate as pulp capping agents: An animal study.Journal of conservative dentistry and endodontics · 2025Article
- Treatment Outcomes of Revascularization and Cervical Pulpotomy in Immature Traumatized Maxillary Incisors: A Case Report With 24 Months Follow-Up.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preserving pulp vitality is crucial for maintaining tooth function and structure. Vital pulp therapy uses pulp capping agents to promote pulp healing and regeneration. Aims: This study evaluated the outcomes of four different pulp capping agents. Materials and Methods: One hundred and twenty patients were randomly assigned to four groups: G1 - calcium hydroxide (CH), G2 - growth factor (Recombinant human Platelet-Derived Growth Factor-BB + Beta-Tricalcium Phosphate (rh-PDGF-bb+ βTCP)), G3 - Biodentine, and G4 - Results: The highest success rate was observed in the growth factor group (96.7%), followed by Biodentine (93.3%), CQ (90%), and CH (80%). However, the differences among groups were not statistically significant ( Conclusion: Growth factor (rh-PDGF-bb + βTCP) demonstrated the highest success rate, positioning it as a superior alternative to CH. CQ also showed potential as an effective pulp capping agent, warranting further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.